Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
暂无分享,去创建一个
Eric P. Hoffman | Zheng Fan | Xiao Xiao | Martin A. Styner | Joe N. Kornegay | Robert W. Grange | Kevin M. Flanigan | E. Hoffman | M. Styner | K. Flanigan | R. Grange | J. Kornegay | S. Schatzberg | M. Childers | J. Bogan | D. Bogan | Juan Li | P. Nghiem | David A. Detwiler | C. A. Larsen | R. Bhavaraju-Sanka | S. Tou | B. Keene | J. Howard | Jiahui Wang | Zheng Fan | Xiao Xiao | Janet R. Bogan | Daniel J. Bogan | Martin K. Childers | Juan Li | Peter Nghiem | C. Aaron Larsen | Ratna K. Bhavaraju-Sanka | Sandra Tou | Bruce P. Keene | James F. Jr. Howard | Jiahui Wang | Scott J. Schatzberg | Xiao Xiao | Ratna K. Bhavaraju-Sanka
[1] P. Vignos,et al. Maintenance of ambulation in childhood muscular dystrophy. , 1960, Journal of chronic diseases.
[2] P. Vignos,et al. Management of progressive muscular dystrophy in childhood. , 1963, JAMA.
[3] F. Buchthal,et al. Chapter VI Electrophysiological Aspects of Myopathy with Particular Reference to Progressive Muscular Dystrophy , 1963 .
[4] G. Bourne,et al. Muscular Dystrophy in Man and Animals , 1964 .
[5] I. Siegel,et al. Subcutaneous lower limb tenotomy in the treatment of pseudohypertrophic muscular dystrophy. Description of technique and presentation of twenty-one cases. , 1968, The Journal of bone and joint surgery. American volume.
[6] J. Desmedt,et al. Regeneration in Duchenne muscular dystrophy. Electromyographic evidence. , 1976, Archives of neurology.
[7] M. Grounds,et al. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts , 1978, Nature.
[8] R. Nussbaum,et al. Sporadic occurrence of Duchenne Muscular Dystrophy: evidence for new mutation , 1980, Clinical genetics.
[9] J. Cowan,et al. Incidence of Duchenne muscular dystrophy in New South Wales and Australian Capital Territory. , 1980 .
[10] M. Zatz,et al. Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency. , 1981, American journal of medical genetics.
[11] M. Zatz,et al. Begnign duchenne muscular dystrophy in a patient with growth hormone deficiency , 1981 .
[12] J. Miller,et al. Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history , 1983, Muscle & nerve.
[13] D. Newham,et al. ROLE OF MECHANICAL DAMAGE IN PATHOGENESIS OF PROXIMAL MYOPATHY IN MAN , 1984, The Lancet.
[14] K. Moore,et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[15] E. Stålberg,et al. Causes of the increased fiber density in muscular dystrophies studied with single fiber EMG during electrical stimulation , 1985, Muscle & nerve.
[16] Eric P. Hoffman,et al. Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.
[17] B. Cooper,et al. Canine X-linked muscular dystrophy An animal model of Duchenne muscular dystrophy: Clinical studies , 1988, Journal of the Neurological Sciences.
[18] M. W. Thompson,et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. , 1988, Science.
[19] Eric P. Hoffman,et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs , 1988, Nature.
[20] Doris M. Miller,et al. Muscular dystrophy in a litter of golden retriever dogs , 1988, Muscle & nerve.
[21] J. Kornegay,et al. Clinical electromyographic studies of canine X-linked muscular dystrophy. , 1989, American journal of veterinary research.
[22] L. Kunkel,et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.
[23] B. Cooper,et al. Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model. , 1989, The American journal of pathology.
[24] A. Lamminen,et al. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. , 1990, The British journal of radiology.
[25] M. Brooke,et al. Randomized, double‐blind trial of mazindol in Duchenne dystrophy , 1990, Muscle & nerve.
[26] B. Cooper,et al. Canine X-linked muscular dystrophy: Morphologic lesions , 1990, Journal of the Neurological Sciences.
[27] H Sugita,et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. , 1991, American journal of human genetics.
[28] R. Gilmour,et al. Duchenne's cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies. , 1991, Journal of the American College of Cardiology.
[29] R. Bartlett,et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. , 1992, Genomics.
[30] A. Roses,et al. Duchenne Muscular Dystrophy: Animal Models and Genetic Manipulation , 1992 .
[31] T. Furlong. Myoblast transplantation. , 1992, Science.
[32] J. Kornegay,et al. Stimulated single fibre electromyography in normal dogs , 1993 .
[33] W. King,et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. , 1993, Human molecular genetics.
[34] M. Esler,et al. Non-invasive evaluation of the cardiac function in Golden Retriever dogs by radionuclide angiography , 1993, Neuromuscular Disorders.
[35] D. Watt,et al. Magnetic affinity cell sorting (MACS) separation and flow cytometric characterization of neural cell adhesion molecule-positive, cultured myogenic cells from normal and dystrophic dogs. , 1993, Experimental cell research.
[36] C. Richards,et al. Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy , 1993, Cell transplantation.
[37] George Karpati,et al. Myoblast transfer in duchenne muscular dystrophy , 1993, Annals of neurology.
[38] G. Liu,et al. Duchenne muscular dystrophy: MR grading system with functional correlation. , 1993, Radiology.
[39] J. Kornegay,et al. Tarsal joint contracture in dogs with golden retriever muscular dystrophy. , 1994, Laboratory animal science.
[40] J. Kornegay,et al. Contraction tension and kinetics of the peroneus longus muscle in golden retriever muscular dystrophy , 1994, Journal of the Neurological Sciences.
[41] D. Zipes,et al. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. , 1995, The Journal of clinical investigation.
[42] L. Politano,et al. Evaluation of the cardiomyopathy in becker muscular dystrophy , 1995, Muscle & nerve.
[43] S D Nandedkar,et al. Multi‐motor unit action potential analysis (MMA) , 1995, Muscle & nerve.
[44] S. Wheeler,et al. Neospora caninum infection in three dogs. , 1995, The Journal of small animal practice.
[45] R. Abresch,et al. Profiles of neuromuscular diseases. Becker's muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.
[46] J. Tidball,et al. Calpains Are Activated in Necrotic Fibers from mdx Dystrophic Mice (*) , 1995, The Journal of Biological Chemistry.
[47] D. Brems,et al. Kinetic Analysis of the Folding of Human Growth Hormone , 1995, The Journal of Biological Chemistry.
[48] M. Akaike,et al. Cardiac dysfunction with Becker muscular dystrophy. , 1996, American heart journal.
[49] G. Danieli,et al. Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. , 1996, Circulation.
[50] D B Sanders,et al. AAEM minimonograph #25: Single‐fiber electromyography , 1996, Muscle & nerve.
[51] M. Grounds,et al. Rapid death of injected myoblasts in myoblast transfer therapy , 1996, Muscle & nerve.
[52] L. Kunkel,et al. Dystrophies and heart disease. , 1997, Current opinion in cardiology.
[53] L. Kunkel,et al. The fate of individual myoblasts after transplantation into muscles of DMD patients , 1997, Nature Medicine.
[54] H. Blau,et al. Myoblast implantation in Duchenne muscular dystrophy: The San Francisco study , 1997, Muscle & nerve.
[55] Se-Jin Lee,et al. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.
[56] T. Kikuchi. Canine X-linked Muscular Dystrophy. , 1997 .
[57] J. Kornegay,et al. Evaluating motor end‐plate‐targeted injections of botulinum toxin type A in a canine model , 1998, Muscle & nerve.
[58] J. Tremblay,et al. Myoblast transplantation in non-dystrophic dog , 1998, Neuromuscular Disorders.
[59] S. Fletcher,et al. Direct dystrophin and reporter gene transfer into dog muscle in vivo , 1998, Muscle & nerve.
[60] Hanns Lochmüller,et al. High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. , 1998, Human gene therapy.
[61] L. Morandi,et al. Development of muscle pathology in canine X-linked muscular dystrophy. I. Delayed postnatal maturation of affected and normal muscle as revealed by myosin isoform analysis and utrophin expression , 1999, Acta Neuropathologica.
[62] J. Kornegay,et al. Contraction force generated by tarsal joint flexion and extension in dogs with golden retriever muscular dystrophy , 1999, Journal of the Neurological Sciences.
[63] J. Oosterwijk,et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy , 1999, Neuromuscular Disorders.
[64] C. Langford,et al. Molecular analysis of a spontaneous dystrophin `knockout' dog , 1999, Neuromuscular Disorders.
[65] L. De Angelis,et al. Skeletal Myogenic Progenitors Originating from Embryonic Dorsal Aorta Coexpress Endothelial and Myogenic Markers and Contribute to Postnatal Muscle Growth and Regeneration , 1999, The Journal of cell biology.
[66] Se-Jin Lee,et al. Myostatin and the control of skeletal muscle mass. , 1999, Current opinion in genetics & development.
[67] F. Muntoni,et al. X-linked dilated cardiomyopathy and the dystrophin gene , 1999, Neuromuscular Disorders.
[68] Eric P. Hoffman,et al. Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology , 2000 .
[69] M. Badalamente,et al. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition , 2000, Muscle & nerve.
[70] W. T. Bartlett,et al. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide , 2000, Nature Biotechnology.
[71] M. Grounds,et al. Problems and solutions in myoblast transfer therapy , 2001, Journal of cellular and molecular medicine.
[72] F L Mastaglia,et al. Patterns of muscle involvement in inclusion body myositis: Clinical and magnetic resonance imaging study , 2001, Muscle & nerve.
[73] J. Nalbantoglu,et al. Dystrophin expression in muscle following gene transfer with a fully deleted ("gutted") adenovirus is markedly improved by trans-acting adenoviral gene products. , 2001, Human gene therapy.
[74] J. Kornegay,et al. Myofiber Injury and Regeneration in a Canine Homologue of Duchenne Muscular Dystrophy , 2001, American journal of physical medicine & rehabilitation.
[75] F. Cozzi,et al. Development of muscle pathology in canine X-linked muscular dystrophy. II. Quantitative characterization of histopathological progression during postnatal skeletal muscle development , 2001, Acta Neuropathologica.
[76] S. Salani,et al. A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse. , 2002, Experimental cell research.
[77] K. McDonald,et al. Eccentric contraction injury in dystrophic canine muscle. , 2002, Archives of physical medicine and rehabilitation.
[78] K. Wagner,et al. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice , 2002, Annals of neurology.
[79] J. D. Porter,et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. , 2002, Human molecular genetics.
[80] M. Baiocchi,et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. , 2002, Development.
[81] Se-Jin Lee,et al. Suppression of body fat accumulation in myostatin-deficient mice. , 2002, The Journal of clinical investigation.
[82] F. Nguyen,et al. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies. , 2002, Journal of comparative pathology.
[83] Denis J Marcellin-Little,et al. Reliability of goniometry in Labrador Retrievers. , 2002, American journal of veterinary research.
[84] Mei Han,et al. Gene expression profiling of Duchenne muscular dystrophy skeletal muscle , 2003, Neurogenetics.
[85] F. Muntoni. Cardiomyopathy in muscular dystrophies , 2003, Current opinion in neurology.
[86] K. Davies,et al. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer , 2003, Gene Therapy.
[87] I. Nonaka,et al. Canine X-linked muscular dystrophy in Japan (CXMDJ). , 2003, Experimental animals.
[88] J. Kornegay,et al. The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy , 2003, Neuromuscular Disorders.
[89] Mariana Salimena,et al. Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice , 2000, Histochemistry and Cell Biology.
[90] S. Tapscott,et al. expression in Duchenne muscular dystrophy dogs Hematopoietic stem cell transplantation does not restore dystrophin , 2013 .
[91] J. Thibaud,et al. Tissue Doppler assessment of diastolic and systolic alterations of radial and longitudinal left ventricular motions in Golden Retrievers during the preclinical phase of cardiomyopathy associated with muscular dystrophy. , 2004, American journal of veterinary research.
[92] L. Kunkel,et al. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction , 1990, Human Genetics.
[93] J. Kornegay,et al. Effects of prednisone in canine muscular dystrophy , 2004, Muscle & nerve.
[94] J. Gillis,et al. Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse , 1999, Journal of Muscle Research & Cell Motility.
[95] A. Connolly,et al. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging , 2005, Skeletal Radiology.
[96] R. Hamlin,et al. Evaluation of the six-minute walk test in dogs. , 2004, American journal of veterinary research.
[97] G. Maréchal,et al. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch , 1993, Journal of Muscle Research & Cell Motility.
[98] E. Engvall,et al. Muscular dystrophy with truncated dystrophin in a family of Japanese Spitz dogs , 2004, Journal of the Neurological Sciences.
[99] K. Wulff,et al. Deletion screening in patients with Duchenne muscular dystrophy , 1989, Journal of Neurology.
[100] Se-Jin Lee. Regulation of muscle mass by myostatin. , 2004, Annual review of cell and developmental biology.
[101] R. Parks,et al. Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[102] R. Mansourian,et al. The development of a high-density canine microarray. , 2005, The Journal of heredity.
[103] J. Belmont,et al. Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy , 2005, Circulation.
[104] J. T. Dunnen,et al. Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort , 2005, American journal of medical genetics. Part A.
[105] K. Wagner,et al. Muscle regeneration in the prolonged absence of myostatin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[106] Thomas W Prior,et al. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. , 2005, The Journal of molecular diagnostics : JMD.
[107] A. Nakamura,et al. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. , 2005, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[108] G. Meola. Advanced microscopic and histochemical techniques: diagnostic tools in the molecular era of myology. , 2005, European journal of histochemistry : EJH.
[109] Guido Gerig,et al. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.
[110] 直子 弓削田. Canine X-Linked Muscular Dystrophy in Japan(CXMD[J])における心機能障害の病態に関する研究 , 2008 .
[111] A. Nakamura,et al. Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies , 2006, BMC cardiovascular disorders.
[112] F. Marden,et al. The use of MRI in the evaluation of myopathy , 2006, Clinical Neurophysiology.
[113] Giulio Cossu,et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs , 2006, Nature.
[114] J. Kornegay,et al. Radiographic features of Golden Retriever muscular dystrophy. , 2006, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[115] James M. Allen,et al. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[116] F. Sotgia,et al. Localized Treatment with a Novel FDA-Approved Proteasome Inhibitor Blocks the Degradation of Dystrophin and Dystrophin-Associated Proteins in mdx Mice , 2007, Cell cycle.
[117] W. Baltzer,et al. Dystrophin-deficient muscular dystrophy in a Weimaraner. , 2007, Journal of the American Animal Hospital Association.
[118] J. Tremblay,et al. Ischemic Central Necrosis in Pockets of Transplanted Myoblasts in Nonhuman Primates: Implications for Cell-Transplantation Strategies , 2007, Transplantation.
[119] S. Takeda,et al. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products , 2007, Gene Therapy.
[120] A. Bretag. Stem cell treatment of dystrophic dogs , 2007, Nature.
[121] P. Carlier,et al. Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging , 2007, Neuromuscular Disorders.
[122] C. McGowan,et al. Determinants of passive hip range of motion in adult Greyhounds. , 2007, Australian veterinary journal.
[123] D. Goudie,et al. Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland , 2007, Heart.
[124] S. Tapscott,et al. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. , 2006, Human gene therapy.
[125] M. Zatz,et al. Muscular dystrophy-related quantitative and chemical changes in adenohypophysis GH-cells in golden retrievers. , 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[126] C. Bustamante,et al. A Mutation in the Myostatin Gene Increases Muscle Mass and Enhances Racing Performance in Heterozygote Dogs , 2007, PLoS genetics.
[127] R. F. Hoyt,et al. Myocardial Fibro-fatty Infiltration in Duchenne Muscular Dystrophy Canine Model Detected using Multi-echo Dixon Method of Water and Fat Separation Imaging , 2008 .
[128] I. Kerkis,et al. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? , 2008, Journal of Translational Medicine.
[129] J. Kornegay,et al. A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[130] P. Day,et al. Gene expression profiling of normal and ruptured canine anterior cruciate ligaments. , 2008, Osteoarthritis and cartilage.
[131] S. Tapscott,et al. Hematopoietic Cell Transplantation Provides an Immune-tolerant Platform for Myoblast Transplantation in Dystrophic Dogs , 2008, Molecular Therapy.
[132] S. Colan,et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. , 2008, American heart journal.
[133] M. Zatz,et al. Ringo, a Golden Retriever Muscular Dystrophy (GRMD) dog with absent dystrophin but normal strength , 2008, Neuromuscular Disorders.
[134] J. Kornegay,et al. Hydrodynamic limb vein injection of AAV8 canine myostatin propeptide gene in normal dogs enhances muscle growth , 2008 .
[135] J. Kopeć,et al. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part I: Electromyographic pattern in subsequent stages of muscle lesion in Duchenne muscular dystrophy. , 2008, Electromyography and clinical neurophysiology.
[136] Akinori Nakamura,et al. Evaluation of dystrophic dog pathology by fat‐suppressed T2‐weighted imaging , 2009, Muscle & nerve.
[137] E. Barrey,et al. Gait analysis using accelerometry in dystrophin-deficient dogs , 2009, Neuromuscular Disorders.
[138] C. Ambrósio,et al. Identification of three distinguishable phenotypes in golden retriever muscular dystrophy. , 2009 .
[139] C. Zhang,et al. Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. , 2009, Human gene therapy.
[140] 大島 幸子,et al. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle , 2009 .
[141] Akinori Nakamura,et al. Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs , 2009, Annals of neurology.
[142] Freddie H. Fu,et al. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin‐deficient mice , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[143] K. Nagaraju,et al. Developing standard procedures for murine and canine efficacy studies of DMD therapeutics: report of two expert workshops on “Pre-clinical testing for Duchenne dystrophy”: Washington DC, October 27th–28th 2007 and Zürich, June 30th-July 1st 2008 , 2009, Neuromuscular Disorders.
[144] Livija Medne,et al. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort , 2009, Human mutation.
[145] J. Kornegay,et al. Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[146] F. Muntoni,et al. A Duchenne Muscular Dystrophy Gene Hot Spot Mutation in Dystrophin-Deficient Cavalier King Charles Spaniels Is Amenable to Exon 51 Skipping , 2010, PloS one.
[147] Jay J. Han,et al. The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy , 2010, Muscle & nerve.
[148] J. Mendell,et al. Dystrophin immunity in Duchenne's muscular dystrophy. , 2010, The New England journal of medicine.
[149] J. Kornegay,et al. Expression of dog microdystrophin in mouse and dog muscles by gene therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[150] S. Tapscott,et al. Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[151] Joe N. Kornegay,et al. Kinematics of gait in Golden Retriever Muscular Dystrophy , 2010, Neuromuscular Disorders.
[152] J. Kornegay,et al. Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. , 2010, The Journal of clinical investigation.
[153] Doug Case,et al. Eccentric contractions induce rapid isometric torque drop in dystrophin‐deficient dogs , 2010, Muscle & nerve.
[154] H. Sweeney,et al. Leupeptin-based inhibitors do not improve the mdx phenotype. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.
[155] M. Fiszman,et al. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs. , 2011, The American journal of pathology.
[156] M. Zatz,et al. Preclinical Studies with Umbilical Cord Mesenchymal Stromal Cells in Different Animal Models for Muscular Dystrophy , 2011, Journal of biomedicine & biotechnology.
[157] J. Kornegay,et al. Muscular Dystrophy in Dogs , 2011, Veterinary pathology.
[158] J. Min,et al. Regulation of the calpain and ubiquitin‐proteasome systems in a canine model of muscular dystrophy , 2011, Muscle & nerve.
[159] Zheng Fan,et al. MRI-based quantification of Duchenne muscular dystrophy in a canine model , 2011, Medical Imaging.
[160] D. Duan,et al. Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs , 2011, Neuromuscular Disorders.
[161] K. Davies,et al. Therapeutic approaches to muscular dystrophy. , 2011, Human molecular genetics.
[162] J. Bourke,et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study , 2011, The Lancet.
[163] R. Grange,et al. In vivo canine muscle function assay. , 2011, Journal of visualized experiments : JoVE.
[164] Eric Barrey,et al. Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs , 2011, BMC musculoskeletal disorders.
[165] R. Grange,et al. Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements. , 2011, Methods in molecular biology.
[166] H. Sweeney,et al. Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. , 2011, Human gene therapy.
[167] J. Kornegay,et al. An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed , 2010, Laboratory Investigation.
[168] M. Zatz,et al. Human Adipose-Derived Mesenchymal Stromal Cells Injected Systemically into GRMD Dogs without Immunosuppression are Able to Reach the Host Muscle and Express Human Dystrophin , 2012, Cell transplantation.
[169] H. An,et al. Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[170] R. Kotin,et al. Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[171] Joe N. Kornegay,et al. Chronic Administration of a Leupeptin-Derived Calpain Inhibitor Fails to Ameliorate Severe Muscle Pathology in a Canine Model of Duchenne Muscular Dystrophy , 2011, Front. Pharmacol..
[172] J. Cullen,et al. Cardiac structure and function in female carriers of a canine model of Duchenne muscular dystrophy. , 2013, Research in veterinary science.
[173] G. Serratrice,et al. Muscle hypertrophy in Duchenne muscular dystrophy A pathological and morphometric study , 2022 .